Original Report

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months†

  1. Björn Wettermark M.Sc.Pharm, PhD1,2,‡,*,
  2. Niklas Hammar Assoc. professor3,4,‡,
  3. C. MichaelFored MD, PhD5,‡,
  4. Andrejs Leimanis6,
  5. Petra Otterblad Olausson PhD6,
  6. Ulf Bergman MD, professor1,
  7. Ingemar Persson MD, professor7,8,
  8. Anders Sundström MD, PhD9,
  9. Barbro Westerholm MD, professor9,
  10. Måns Rosén MD, professor6

Article first published online: 9 AUG 2006

DOI: 10.1002/pds.1294

Issue

Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety

Volume 16, Issue 7, pages 726–735, July 2007

Additional Information

How to Cite

Wettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B. and Rosén, M. (2007), The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidem. Drug Safe., 16: 726–735. doi: 10.1002/pds.1294

Author Information

  1. 1

    Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge. WHO collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, and Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden

  2. 2

    National Corporation of Pharmacies (Apoteket AB), Stockholm, Sweden

  3. 3

    Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  4. 4

    Department of Epidemiology, AstraZeneca Research and Development, Mölndal, Sweden

  5. 5

    Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, and Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden

  6. 6

    Centre for Epidemiology, Swedish National Board of Health and Welfare, Stockholm, Sweden

  7. 7

    Medical Products Agency, Uppsala, Sweden

  8. 8

    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  9. 9

    Swedish Association of Senior Citizens, Stockholm, Sweden

  1. ‡

    Board member, Swedish Society for Pharmacoepidemiology.

*Apoteket AB, 131 88 Stockholm, Sweden.

  1. †

    No conflict of interest was declared.

Publication History

  1. Issue published online: 28 JUN 2007
  2. Article first published online: 9 AUG 2006
  3. Manuscript Accepted: 18 JUN 2006
  4. Manuscript Revised: 15 JUN 2006
  5. Manuscript Received: 31 MAY 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (149K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (149K)